{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T05:59:29Z","timestamp":1769147969677,"version":"3.49.0"},"reference-count":39,"publisher":"International Heart Journal (Japanese Heart Journal)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. Heart J."],"published-print":{"date-parts":[[2018,9,1]]},"DOI":"10.1536\/ihj.17-565","type":"journal-article","created":{"date-parts":[[2018,8,10]],"date-time":"2018-08-10T22:26:29Z","timestamp":1533939989000},"page":"1123-1133","source":"Crossref","is-referenced-by-count":54,"title":["Chronic Pressure Overload Induces Cardiac Hypertrophy and Fibrosis via Increases in SGLT1 and IL-18 Gene Expression in Mice"],"prefix":"10.1536","volume":"59","author":[{"given":"Naoko","family":"Matsushita","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Iwate Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nanae","family":"Ishida","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cellular Pharmacology, Iwate Medical University School of Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miho","family":"Ibi","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cellular Pharmacology, Iwate Medical University School of Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maki","family":"Saito","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cellular Pharmacology, Iwate Medical University School of Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Sanbe","sequence":"additional","affiliation":[{"name":"Department of Pharmacotherapy, Iwate Medical University School of Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Shimojo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Shinshu University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Suzuki","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Hematology, Fukushima Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hermann","family":"Koepsell","sequence":"additional","affiliation":[{"name":"Department of Molecular Plant Physiology and Biophysics, Julius-von-Sachs-Institute, University of W\u00fcrzburg"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuchika","family":"Takeishi","sequence":"additional","affiliation":[{"name":"Department of Cardiology and Hematology, Fukushima Medical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Morino","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Iwate Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiichi","family":"Taira","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Iwate Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Sawa","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Iwate Medical University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masamichi","family":"Hirose","sequence":"additional","affiliation":[{"name":"Department of Molecular and Cellular Pharmacology, Iwate Medical University School of Pharmaceutical Sciences"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"437","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322: 1561-6.","DOI":"10.1056\/NEJM199005313222203"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Rapacciuolo A, Esposito G, Caron K, Mao L, Thomas SA, Rockman HA. Important role of endogenous norepinephrine and epinephrine in the development of in vivo pressure overload cardiac hypertrophy. J Am Coll Cardiol 2001; 38: 876-82.","DOI":"10.1016\/S0735-1097(01)01433-4"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Rockman HA, Wachhorst SP, Mao L, Ross J Jr. ANG II receptor blockade prevents ventricular hypertrophy and ANF gene expression with pressure overload in mice. Am J Physiol 1994; 266: H2468-75.","DOI":"10.1152\/ajpheart.1994.266.6.H2468"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Katanasaka Y, Suzuki H, Sunagawa Y, Hasegawa K, Morimoto T. Regulation of cardiac transcription factor GATA4 by post-translational modification in cardiomyocyte hypertrophy and heart failure. Int Heart J 2016; 57: 672-5.","DOI":"10.1536\/ihj.16-404"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Niizeki T, Takeishi Y, Kitahara T, <i>et al<\/i>. Diacylglycerol kinase-epsilon restores cardiac dysfunction under chronic pressure overload: a new specific regulator of Galpha (q) signaling cascade. Am J Physiol Heart Circ Physiol 2008; 295: H245-55.","DOI":"10.1152\/ajpheart.00066.2008"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Banerjee SK, McGaffin KR, Pastor-Soler NM, Ahmad F. SGLT1 is a novel cardiac glucose transporter that is perturbed in disease states. Cardiovasc Res 2009; 84: 111-8.","DOI":"10.1093\/cvr\/cvp190"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Di Franco A, Cantini G, Tani A, <i>et al<\/i>. Sodium-dependent glucose transporters (SGLT) in human ischemic heart: A new potential pharmacological target. Int J Cardiol 2017; 243: 86-90.","DOI":"10.1016\/j.ijcard.2017.05.032"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Ramratnam M, Sharma RK, D&apos;Auria S, <i>et al<\/i>. Transgenic knockdown of cardiac sodium\/glucose cotransporter 1 (SGLT1) attenuates PRKAG2 cardiomyopathy, whereas transgenic overexpression of cardiac SGLT1 causes pathologic hypertrophy and dysfunction in mice. J Am Heart Assoc 2014; 3: e000899.","DOI":"10.1161\/JAHA.114.000899"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Zhabyeyev P, Gandhi M, Mori J, <i>et al<\/i>. Pressure overload-induced heart failure induces a selective reduction in glucose oxidation at physiological afterload. Cardiovasc Res 2013; 97: 676-85.","DOI":"10.1093\/cvr\/cvs424"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Banerjee SK, Wang DW, Alzamora R, <i>et al<\/i>. SGLT1, a novel cardiac glucose transporter, mediates increased glucose uptake in PRKAG2 cardiomyopathy. J Mol Cell Cardiol 2010; 49: 683-92.","DOI":"10.1016\/j.yjmcc.2010.06.003"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Meng R, Pei Z, Zhang A, <i>et al<\/i>. AMPK activation enhances PPAR\u03b1 activity to inhibit cardiac hypertrophy via ERK1\/2 MAPK signaling pathway. Arch Biochem Biophys 2011; 511: 1-7.","DOI":"10.1016\/j.abb.2011.04.010"},{"key":"12","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2337\/db11-1029","volume":"61","year":"2012","unstructured":"12. Gorboulev V, Sch\u00fcrmann A, Vallon V, <i>et al<\/i>. Na(+)-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion. Diabetes 2012; 61: 187-96.","journal-title":"Diabetes","ISSN":"https:\/\/id.crossref.org\/issn\/0012-1797","issn-type":"print"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Kamiyoshi Y, Takahashi M, Yokoseki O, <i>et al<\/i>. Mycophenolate mofetil prevents the development of experimental autoimmune myocarditis. J Mol Cell Cardiol 2005; 39: 467-77.","DOI":"10.1016\/j.yjmcc.2005.04.004"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Hirose M, Takeishi Y, Niizeki T, <i>et al<\/i>. Diacylglycerol kinase \u03b6 inhibits G\u03b1q-induced atrial remodeling in transgenic mice. Heart Rhythm 2009; 6: 78-84.","DOI":"10.1016\/j.hrthm.2008.10.018"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Sanbe A, Marunouchi T, Abe T, <i>et al<\/i>. Phenotype of cardiomyopathy in cardiac-specific heat shock protein B8 K141N transgenic mouse. J Biol Chem 2013; 288: 8910-21.","DOI":"10.1074\/jbc.M112.368324"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Hiroyama M, Wang S, Aoyagi T, <i>et al<\/i>. Vasopressin promotes cardiomyocyte hypertrophy via the vasopressin V1A receptor in neonatal mice. Eur J Pharmacol 2007; 559: 89-97.","DOI":"10.1016\/j.ejphar.2006.12.010"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Onohara N, Nishida M, Inoue R, <i>et al<\/i>. TRPC3 and TRPC6 are essential for angiotensin II-induced cardiac hypertrophy. EMBO J 2006; 25: 5305-16.","DOI":"10.1038\/sj.emboj.7601417"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Lambert R, Srodulski S, Peng X, Margulies KB, Despa F, Despa S. Intracellular Na+ Concentration ([Na+]i) is Elevated in diabetic hearts due to enhanced Na+-Glucose cotransport. J Am Heart Assoc 2015; 4: e002183.","DOI":"10.1161\/JAHA.115.002183"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Nakamura TY, Iwata Y, Arai Y, Komamura K, Wakabayashi S. Activation of Na<sup>+\/<\/sup>H<sup>+<\/sup> exchanger 1 is sufficient to generate Ca2+ signals that induce cardiac hypertrophy and heart failure. Circ Res 2008; 103: 891-9.","DOI":"10.1161\/CIRCRESAHA.108.175141"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kashiwase K, Higuchi Y, Hirotani S, <i>et al<\/i>. CaMKII activates ASK1 and NF-kappaB to induce cardiomyocyte hypertrophy. Biochem Biophys Res Commun 2005; 327: 136-42.","DOI":"10.1016\/j.bbrc.2004.12.002"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Tanaka T, Ogawa M, Suzuki J, <i>et al<\/i>. Inhibition of I\u03baB phosphorylation prevents load-induced cardiac dysfunction in mice. Am J Physiol Heart Circ Physiol 2012; 303: H1435-45.","DOI":"10.1152\/ajpheart.00290.2012"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Yoshida T, Friehs I, Mummidi S, <i>et al<\/i>. Pressure overload induces IL-18 and IL-18R expression, but markedly suppresses IL-18BP expression in a rabbit model. IL-18 potentiates TNF-\u03b1-induced cardiomyocyte death. J Mol Cell Cardiol 2014; 75: 141-51.","DOI":"10.1016\/j.yjmcc.2014.07.007"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Reddy VS, Prabhu SD, Mummidi S, <i>et al<\/i>. Interleukin-18 induces EMMPRIN expression in primary cardiomyocytes via JNK\/Sp1 signaling and MMP-9 in part via EMMPRIN and through AP-1 and NF-kappaB activation. Am J Physiol Heart Circ Physiol 2010; 299: H1242-54.","DOI":"10.1152\/ajpheart.00451.2010"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Colston JT, Boylston WH, Feldman MD, <i>et al<\/i>. Interleukin-18 knockout mice display maladaptive cardiac hypertrophy in response to pressure overload. Biochem Biophys Res Commun 2007; 354: 552-8.","DOI":"10.1016\/j.bbrc.2007.01.030"},{"key":"25","unstructured":"25. Cao W, Zou Y, Su S, <i>et al<\/i>. Chlamydial plasmid-encoded protein pORF5 induces production of IL-1\u03b2 and IL-18 via NALP3 inflammasome activation and p38 MAPK pathway. Int J Clin Exp Med 2015; 8: 20368-79."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Nagoshi T, Yoshimura M, Rosano GM, Lopaschuk GD, Mochizuki S. Optimization of cardiac metabolism in heart failure. Curr Pharm Des 2011; 17: 3846-53.","DOI":"10.2174\/138161211798357773"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Kashiwagi Y, Nagoshi T, Yoshino T, <i>et al<\/i>. Expression of SGLT1 in human hearts and impairment of cardiac glucose uptake by phlorizin during ischemia-reperfusion injury in mice. PLoS One 2015; 10: e0130605.","DOI":"10.1371\/journal.pone.0130605"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Endo J, Sano M, Katayama T, <i>et al<\/i>. Metabolic remodeling induced by mitochondrial aldehyde stress stimulates tolerance to oxidative stress in the heart. Circ Res 2009; 105: 1118-27.","DOI":"10.1161\/CIRCRESAHA.109.206607"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Hudlicka O, Brown M, Egginton S. Angiogenesis in skeletal and cardiac muscle. Physiol Rev 1992; 72: 369-417.","DOI":"10.1152\/physrev.1992.72.2.369"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Shiojima I, Sato K, Izumiya Y, <i>et al<\/i>. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 2005; 115: 2108-18.","DOI":"10.1172\/JCI24682"},{"key":"31","doi-asserted-by":"publisher","unstructured":"31. Izumiya Y, Shiojima I, Sato K, Sawyer DB, Colucci WS, Walsh K. Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload. Hypertension 2006; 47: 887-93.","DOI":"10.1161\/01.HYP.0000215207.54689.31"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Jia Z, Xue R, Liu G, <i>et al<\/i>. HMGB1 is involved in the protective effect of the PPAR \u03b1 agonist fenofibrate against cardiac hypertrophy. PPAR Res 2014; 2014: 541394.","DOI":"10.1155\/2014\/541394"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Wang Q, Oka T, Yamagami K, <i>et al<\/i>. An EP4 Receptor Agonist Inhibits Cardiac Fibrosis Through Activation of PKA Signaling in Hypertrophied Heart. Int Heart J 2017; 58: 107-14.","DOI":"10.1536\/ihj.16-200"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Li R, Lu K, Wang Y, <i>et al<\/i>. Triptolide attenuates pressure overload-induced myocardial remodeling in mice via the inhibition of NLRP3 inflammasome expression. Biochem Biophys Res Commun 2017; 485: 69-75.","DOI":"10.1016\/j.bbrc.2017.02.021"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Zhao CH, Ma X, Guo HY, Li P, Liu HY. RIP2 deficiency attenuates cardiac hypertrophy, inflammation and fibrosis in pressure overload induced mice. Biochem Biophys Res Commun 2017; 493: 1151-8.","DOI":"10.1016\/j.bbrc.2017.07.035"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Pereira RO, Wende AR, Olsen C, <i>et al<\/i>. Inducible overexpression of GLUT1 prevents mitochondrial dysfunction and attenuates structural remodeling in pressure overload but does not prevent left ventricular dysfunction. J Am Heart Assoc 2013; 2: e000301.","DOI":"10.1161\/JAHA.113.000301"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Shimizu I, Yoshida Y, Katsuno T, <i>et al<\/i>. p53-induced adipose tissue inflammation is critically involved in the development of insulin resistance in heart failure. Cell Metab 2012; 15: 51-64.","DOI":"10.1016\/j.cmet.2011.12.006"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Barron AJ, Finn SG, Fuller SJ. Chronic activation of extracellular-signal-regulated protein kinases by phenylephrine is required to elicit a hypertrophic response in cardiac myocytes. Biochem J 2003; 371: 71-9.","DOI":"10.1042\/bj20021395"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Pang T, Rajapurohitam V, Cook MA, Karmazyn M. Differential AMPK phosphorylation sites associated with phenylephrine vs. antihypertrophic effects of adenosine agonists in neonatal rat ventricular myocytes. Am J Physiol Heart Circ Physiol 2010; 298: H1382-90.","DOI":"10.1152\/ajpheart.00424.2009"}],"container-title":["International Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/59\/5\/59_17-565\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,22]],"date-time":"2019-10-22T04:27:15Z","timestamp":1571718435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/ihj\/59\/5\/59_17-565\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,1]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1536\/ihj.17-565","relation":{},"ISSN":["1349-2365","1349-3299"],"issn-type":[{"value":"1349-2365","type":"print"},{"value":"1349-3299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,1]]}}}